Pharmaroth Labs Net Income
| ROTH Stock | USD 0.0001 0.00 0.00% |
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmaroth Labs, as well as the relationship between them.
Pharmaroth Labs Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 7.0886 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -82.4 K | -86.5 K | |
| Net Loss | -82.4 K | -86.5 K | |
| Net Loss | -82.4 K | -86.5 K | |
| Net Income Per E B T | 1.15 | 1.09 |
Pharmaroth | Net Income | Build AI portfolio with Pharmaroth Stock |
The Net Income trend for Pharmaroth Labs offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pharmaroth Labs is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pharmaroth Labs' Net Income Growth Pattern
Below is the plot of the Net Income of Pharmaroth Labs over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Pharmaroth Labs financial statement analysis. It represents the amount of money remaining after all of Pharmaroth Labs operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Pharmaroth Labs' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharmaroth Labs' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (91.52 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Pharmaroth Net Income Regression Statistics
| Arithmetic Mean | (159,772) | |
| Coefficient Of Variation | (79.42) | |
| Mean Deviation | 107,532 | |
| Median | (91,521) | |
| Standard Deviation | 126,898 | |
| Sample Variance | 16.1B | |
| Range | 359.3K | |
| R-Value | 0.59 | |
| Mean Square Error | 11.3B | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | 14,727 | |
| Total Sum of Squares | 257.6B |
Pharmaroth Net Income History
Other Fundumenentals of Pharmaroth Labs
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Pharmaroth Labs Net Income component correlations
Pharmaroth Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Pharmaroth Labs is extremely important. It helps to project a fair market value of Pharmaroth Stock properly, considering its historical fundamentals such as Net Income. Since Pharmaroth Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharmaroth Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharmaroth Labs' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Pharmaroth introduce new products? Factors like these will boost the valuation of Pharmaroth Labs. Anticipated expansion of Pharmaroth directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Pharmaroth Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmaroth Labs is measured differently than its book value, which is the value of Pharmaroth that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmaroth Labs' value that differs from its market value or its book value, called intrinsic value, which is Pharmaroth Labs' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Pharmaroth Labs' market value can be influenced by many factors that don't directly affect Pharmaroth Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pharmaroth Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pharmaroth Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pharmaroth Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Pharmaroth Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmaroth Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmaroth Labs.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Pharmaroth Labs on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Pharmaroth Labs or generate 0.0% return on investment in Pharmaroth Labs over 90 days. Pharmaroth Labs is related to or competes with Ligand Pharmaceuticals. PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide More
Pharmaroth Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmaroth Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmaroth Labs upside and downside potential and time the market with a certain degree of confidence.
Pharmaroth Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmaroth Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmaroth Labs' standard deviation. In reality, there are many statistical measures that can use Pharmaroth Labs historical prices to predict the future Pharmaroth Labs' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharmaroth Labs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharmaroth Labs Backtested Returns
We have found three technical indicators for Pharmaroth Labs, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pharmaroth Labs are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Pharmaroth Labs has perfect predictability. Overlapping area represents the amount of predictability between Pharmaroth Labs time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmaroth Labs price movement. The serial correlation of 1.0 indicates that 100.0% of current Pharmaroth Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Pharmaroth Operating Income
Operating Income |
|
Based on the recorded statements, Pharmaroth Labs reported net income of (91,521). This is much lower than that of the Consumer Staples sector and significantly lower than that of the Personal Products industry. The net income for all United States stocks is notably higher than that of the company.
Pharmaroth Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmaroth Labs' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharmaroth Labs could also be used in its relative valuation, which is a method of valuing Pharmaroth Labs by comparing valuation metrics of similar companies.Pharmaroth Labs is currently under evaluation in net income category among its peers.
Pharmaroth Fundamentals
| Profit Margin | (2.79) % | ||||
| Operating Margin | (0.49) % | ||||
| Current Valuation | 1.42 M | ||||
| Shares Outstanding | 149.35 M | ||||
| Price To Earning | (1.22) X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 181.56 K | ||||
| Gross Profit | 80.48 K | ||||
| Net Income | (91.52 K) | ||||
| Cash And Equivalents | 33 | ||||
| Total Debt | 853.53 K | ||||
| Current Ratio | 0.24 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (17.6 K) | ||||
| Beta | -1.67 | ||||
| Market Capitalization | 14.94 K | ||||
| Total Asset | 304.05 K | ||||
| Retained Earnings | (2.89 M) | ||||
| Working Capital | (493 K) | ||||
| Current Asset | 207 K | ||||
| Current Liabilities | 700 K | ||||
| Net Asset | 304.05 K |
About Pharmaroth Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmaroth Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmaroth Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmaroth Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in Pharmaroth Stock please use our How to Invest in Pharmaroth Labs guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is there potential for Biotechnology market expansion? Will Pharmaroth introduce new products? Factors like these will boost the valuation of Pharmaroth Labs. Anticipated expansion of Pharmaroth directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Pharmaroth Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmaroth Labs is measured differently than its book value, which is the value of Pharmaroth that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmaroth Labs' value that differs from its market value or its book value, called intrinsic value, which is Pharmaroth Labs' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Pharmaroth Labs' market value can be influenced by many factors that don't directly affect Pharmaroth Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pharmaroth Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pharmaroth Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pharmaroth Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.